A detailed history of Opaleye Management Inc. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 535,000 shares of RGLS stock, worth $823,900. This represents 0.15% of its overall portfolio holdings.

Number of Shares
535,000
Previous 1,475,000 63.73%
Holding current value
$823,900
Previous $2.64 Million 68.22%
% of portfolio
0.15%
Previous 0.68%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.46 - $1.9 $1.37 Million - $1.79 Million
-940,000 Reduced 63.73%
535,000 $839,000
Q2 2024

Aug 14, 2024

BUY
$1.79 - $2.8 $2.34 Million - $3.65 Million
1,304,692 Added 766.08%
1,475,000 $2.64 Million
Q1 2024

May 15, 2024

BUY
$1.13 - $2.88 $192,448 - $490,487
170,308 New
170,308 $490,000

Others Institutions Holding RGLS

About Regulus Therapeutics Inc.


  • Ticker RGLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,634,400
  • Market Cap $22.5M
  • Description
  • Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...
More about RGLS
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.